Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash flows from operating activities:
Net loss	$ (747,427)	$ (490,735)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	924	3,165
Amortization of intangible assets	36,280	36,281
Amortization of deferred license costs	10,197
Interest income on long-term note receivable	(4,863)
Stock-based compensation	38,764	162,493
Changes in operating assets and liabilities:
Accounts receivable	6,472	(1,210,288)
Contract assets	93,355	247,901
Prepaid expenses and other current assets	(71,440)	205,641
Accounts payable and accrued expenses	(357,323)	(317,983)
Contract liabilities	(31,751)	245,594
Net cash used in operating activities	(1,026,812)	(1,117,931)
Cash flows provided by investing activities:
Advances in note receivable	400,000
Net cash used in investing activities	(400,000)
Cash flows from financing activities:
Proceeds from long-term note payable	200,000
Settlement of common stock from reverse stock split	(122)
Net cash provided by financing activities	199,878
Net decrease in cash and cash equivalents	(1,226,934)	(1,117,931)
Cash and cash equivalents - beginning of period	1,625,671	1,368,395
Cash and cash equivalents - end of period	398,737	250,464
Supplemental disclosure of non-cash operating activities:
Non-cash conversion of accrued salary to restricted stock units		$ 54,315